In another strong week for IPOs, six companies combined to raise $1.2 billion. Five of the six realized positive first-day returns, and three finished their first day up more than 40%. This active week brought the total of 2017 IPOs to 106, passing the total for...read more
Deciphera Pharmaceuticals, which is developing kinase inhibitors for solid tumors, raised $128 million by offering 7.5 million shares at $17, the high end of the range of $15 to $17. Deciphera Pharmaceuticals plans to list on the Nasdaq under the symbol DCPH....read more
Deciphera Pharmaceuticals, a clinical-stage biotech developing kinase inhibitors for solid tumors, announced terms for its IPO on Monday.
The Waltham, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17...read more
US IPO Weekly Recap: Roku streams ahead in week of 6 IPOs
In another strong week for IPOs, six companies combined to raise $1.2 billion. Five of the six realized positive first-day returns, and three finished their first day up more than 40%. This active week brought the total of 2017 IPOs to 106, passing the total for...read more
Cancer biotech Deciphera Pharmaceuticals prices upsized IPO at $17 high end
Deciphera Pharmaceuticals, which is developing kinase inhibitors for solid tumors, raised $128 million by offering 7.5 million shares at $17, the high end of the range of $15 to $17. Deciphera Pharmaceuticals plans to list on the Nasdaq under the symbol DCPH....read more
US IPO Week Ahead: Set-top boxes top off the 3Q17 as Roku headlines 7-IPO week
The IPO market will close out the third quarter with another active week: Seven deals are expected to raise $1.3 billion. High-growth TV streaming...read more
Deciphera Pharmaceuticals sets terms for $100 million IPO
Deciphera Pharmaceuticals, a clinical-stage biotech developing kinase inhibitors for solid tumors, announced terms for its IPO on Monday. The Waltham, MA-based company plans to raise $100 million by offering 6.3 million shares at a price range of $15 to $17...read more